Simon Bowman
Impact in
- Physiology top 0.05%
- Salivary Gland Disorders and Functions
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
Papers in
- Physiology 164
- Salivary Gland Disorders and Functions 164
- Rheumatology 29
- Rheumatoid Arthritis Research and Therapies 15
- Systemic Lupus Erythematosus Research 12
- Co-authors
- Xavier Mariette (22 shared papers)Raphaèle Séror (22 shared papers)Claudio Vitali (9 shared papers)Hendrika Bootsma (15 shared papers)Lindsey A. Criswell (3 shared papers)Athanasios G. Tzioufas (12 shared papers)Stephen C. Shiboski (2 shared papers)Astrid Rasmussen (2 shared papers)
- Journals
- Lara D. Veeken (42 papers)Annals of the Rheumatic Diseases (42 papers)The Lancet (9 papers)RMD Open (8 papers)The Journal of Rheumatology (6 papers)
- Partner nations
- United KingdomFranceUnited States
In The Last Decade
Simon Bowman
225 papers receiving 17.4k citations
Simon Bowman's Hit Papers
Peers
Comparison fields: 5 of 132
- Physiology 8.5k
- Rheumatology 1.5k
- Infectious Diseases 2.0k
- Immunology 385
- Applied Microbiology and Biotechnology 33
Countries citing papers authored by Simon Bowman
This map shows the geographic impact of Simon Bowman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Bowman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Bowman more than expected).
Fields of papers citing papers by Simon Bowman
This network shows the impact of papers produced by Simon Bowman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Bowman. The network helps show where Simon Bowman may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Bowman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 241 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 1531 |
| 2 | 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts Hit paper breakdown → | 2016 | 1379 |
| 3 | 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome Hit paper breakdown → | 2016 | 1082 |
| 4 | EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome Hit paper breakdown → | 2009 | 774 |
| 5 | Sjögren syndrome Hit paper breakdown → | 2016 | 642 |
| 6 | EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies Hit paper breakdown → | 2019 | 455 |
| 7 | 2011 | 435 | |
| 8 | 2013 | 433 | |
| 9 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 10 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 11 | 2008 | 318 | |
| 12 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 13 | 2015 | 271 | |
| 14 | 2014 | 256 | |
| 15 | 2001 | 245 | |
| 16 | 2016 | 234 | |
| 17 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 18 | 2015 | 225 | |
| 19 | 2014 | 221 | |
| 20 | 2017 | 221 |
About Simon Bowman
Simon Bowman is a scholar working on Physiology, Rheumatology, Infectious Diseases, Periodontics and Epidemiology, having authored 241 papers that have together received 18.0k indexed citations. Recurring topics across this work include Salivary Gland Disorders and Functions (164 papers), Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (12 papers), COVID-19 Clinical Research Studies (10 papers), Inflammatory Myopathies and Dermatomyositis (3 papers), Cytomegalovirus and herpesvirus research (2 papers), T-cell and B-cell Immunology (2 papers) and Ethics in Clinical Research (2 papers). The work is most often cited by research in Physiology (8.5k citations), Rheumatology (1.5k citations), Infectious Diseases (2.0k citations), Immunology (385 citations) and Applied Microbiology and Biotechnology (33 citations). Simon Bowman has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Xavier Mariette, Raphaèle Séror, Claudio Vitali, Hendrika Bootsma, Lindsey A. Criswell, Athanasios G. Tzioufas, Stephen C. Shiboski, Astrid Rasmussen, Thomas M. Lietman and Caroline H. Shiboski. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, The Lancet, RMD Open and The Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.